ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

A major government investment in AI for heart failure treatment could improve medical outcomes and advance AI in healthcare.

Auto-scored: Substantial funding for beneficial medical AI development, with no risk elements. · Review in the editor.